What's The Business/Financial Case For Building Capacity?
Source: Outsourced Pharma
We asked our three, non-financial biopharma panelists to make their business/financial case for or against internal build out at emerging companies, particularly for organizations pursuing advanced therapies.
Interested in the complete presentation? Click here.